RENAL SALT-WASTING SYNDROME

This adverse event was reported 204 times

These drugs are most commonly taken by patients reporting RENAL SALT-WASTING SYNDROME:

# Drug Count
0 CISPLATIN 94
1 ETOPOSIDE 45
2 CARBOPLATIN 22
3 FLUOROURACIL 19
4 PREDNISOLONE 15
5 CYCLOPHOSPHAMIDE 14
6 GEMCITABINE HYDROCHLORIDE 14
7 GEMCITABINE 11
8 TACROLIMUS 11
9 DEXAMETHASONE 10
See all common drugs associated with RENAL SALT-WASTING SYNDROME

RENAL SALT-WASTING SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ADEFOVIR DIPIVOXIL 6 0.0019
1 POVIDONE IODINE 10% 1 0.0019
2 CISPLATIN 94 0.0018
3 MITOTANE 1 0.0011
4 ETOPOSIDE 45 0.0010
5 MANNITOL 3 0.0009
6 TERBUTALINE SULFATE 1 0.0008
7 UREA 1 0.0008
8 FOSCARNET SODIUM 2 0.0007
9 VINBLASTINE SULFATE 1 0.0007
See all drugs enriched for association with RENAL SALT-WASTING SYNDROME

RENAL SALT-WASTING SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Topoisomerase Inhibitor [EPC] 115 0.0024
1 Platinum-based Drug [EPC] 188 0.0011
2 Osmotic Diuretic [EPC] 3 0.0008
3 Actinomycin [EPC] 1 0.0005
4 Antiseptic [EPC] 1 0.0003
5 Oxazolidinone Antibacterial [EPC] 6 0.0003
6 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 4 0.0003
7 Phenothiazine [EPC] 5 0.0003
8 Nucleoside Metabolic Inhibitor [EPC] 40 0.0002
9 Lipid-based Polyene Antifungal [EPC] 2 0.0002
See all drug classes enriched for association with RENAL SALT-WASTING SYNDROME